Torrent Pharmaceuticals

Torrent Pharmaceuticals Ltd is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd.

Torrent Pharmaceuticals operates in more than 40 countries with over 2,000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. It also has a presence in therapeutic segments of nephrology, oncology, gynecology and pediatrics.

History
Torrent Pharmaceuticals was established in 1959 by U. N. Mehta as Trinity Laboratories. It was renamed as Torrent Pharmaceuticals in 1971.

In 1997, Torrent Pharma and Sanofi established a 50:50 joint venture called Sanofi Torrent for selling Torrent Pharma's products. Torrent exited the joint venture by selling its stake to Sanofi in 2002.

In 2005, Torrent Pharmaceuticals acquired Heumann Pharma Generics GmbH, a Pfizer company based in Germany.

In 2013, Torrent Pharma acquired the India formulations business of Elder Pharmaceuticals for inr 20040000000.

In 2017, Torrent Pharma acquired the domestic business of Unichem Laboratories for inr 36000000000.

In 2022, the company acquired skincare manufacturer Curatio Healthcare for inr 20000000000.

Subsidiaries
It has 7 fully owned subsidiaries:
 * 1) Heumann Pharma GmbH & Co Generica KG, Germany
 * 2) Torrent Pharma GmbH, Germany
 * 3) Torrent do Brasil Ltda., Brazil
 * 4) ZAO Torrent Pharma, Russia
 * 5) Torrent Pharma Inc., United States
 * 6) Torrent Pharma Philippines Inc., Philippines
 * 7) Torrent Pharma Canada Inc., Canada
 * 8) Torrent Pharma UK United Kingdom

Operations
The company's key areas are Formulations, API, Drug Discovery, Marketing and Sales of Drugs. Its operations locations are:
 * Manufacturing plant at Dahej, Gujarat
 * Manufacturing plant at Pithampur, Madhya Pradesh
 * Manufacturing plant at Indrad, Mehsana, Gujarat
 * Manufacturing plant at Baddi, Himachal Pradesh
 * 3 Manufacturing plant at Rang-Po,(Sikkim)
 * Research Centre, Ahmedabad-Gandhinagar region, Gujarat
 * Corporate Office, beside sales India, off. Ashram Road, [Ahmedabad]- Gujarat
 * Manufacturing plant at Visakhapatnam (Andhra Pradesh)

Recalls
In 2018, Torrent Pharmaceuticals recalled tablets containing valsartan and losartan due to the detection of N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA) respectively which are probable human carcinogens.

In September 2019, the FDA issued notice of a sixth product recall of losartan by Torrent Pharmaceuticals when certain batches of losartan contained the contaminant, N-methylnitrosobutyric acid (NMBA), above acceptable daily intake levels determined by the FDA.